(Q47804429)

English

Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study).

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

author name string

Simons LA

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

Australian and New Zealand journal of medicine

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

28

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

327-333

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01957.X

21 January 2018

What targets should lipid-modulating therapy achieve to optimise the prevention of coronary heart disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01957.X

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01957.X

21 January 2018

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01957.X

21 January 2018

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01957.X

21 January 2018

A brief review paper of the efficacy and safety of atorvastatin in early clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01957.X

21 January 2018

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01957.X

21 January 2018

Identifiers

10.1111/J.1445-5994.1998.TB01957.X

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9673745

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47804429&oldid=1514247709"